Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aijia Li

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Frontiers in Immunology|November 7, 2022
Proteomic and phosphorylated proteomic landscape of injured lung in juvenile septic rats with therapeutic application of umbilical cord mesenchymal stem cellsHongwu Wang, Junlin Luo, Aijia Li, et al.
Trials|February 15, 2019
The cerebral mechanism of acupuncture for treating knee osteoarthritis: study protocol for a randomized controlled trialJing Guo, Yang Chen, Zhengjie Li, et al.
Journal of Thoracic Disease|September 13, 2024
Neoadjuvant camrelizumab followed by concurrent camrelizumab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: a single-arm, phase II studyYinliang Sheng, Xiangrui Meng, Chunyang Zhang, et al.
Cell & Bioscience|July 22, 2022
Single-cell RNA sequencing reveals the potential mechanism of heterogeneity of immunomodulatory properties of foreskin and umbilical cord mesenchymal stromal cellsSiyu Cai, Chuiqin Fan, Lichun Xie, et al.
Journal of Cancer Research and Clinical Oncology|January 27, 2024
Multi-omics and Multi-VOIs to predict esophageal fistula in esophageal cancer patients treated with radiotherapyWei Guo, Bing Li, Wencai Xu, et al.
European Journal of Cancer (Oxford, England : 1990)|September 22, 2024
Efficacy and safety of camrelizumab plus apatinib in patients with advanced esophageal squamous cell carcinoma previously treated with immune checkpoint inhibitors (CAP 02 Re-challenge): A single-arm, phase II studyXiangrui Meng, Junsheng Wang, Jin Xia, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Frontiers in Immunology|November 7, 2022
Proteomic and phosphorylated proteomic landscape of injured lung in juvenile septic rats with therapeutic application of umbilical cord mesenchymal stem cellsHongwu Wang, Junlin Luo, Aijia Li, et al.
Trials|February 15, 2019
The cerebral mechanism of acupuncture for treating knee osteoarthritis: study protocol for a randomized controlled trialJing Guo, Yang Chen, Zhengjie Li, et al.
Journal of Thoracic Disease|September 13, 2024
Neoadjuvant camrelizumab followed by concurrent camrelizumab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: a single-arm, phase II studyYinliang Sheng, Xiangrui Meng, Chunyang Zhang, et al.
Cell & Bioscience|July 22, 2022
Single-cell RNA sequencing reveals the potential mechanism of heterogeneity of immunomodulatory properties of foreskin and umbilical cord mesenchymal stromal cellsSiyu Cai, Chuiqin Fan, Lichun Xie, et al.
Journal of Cancer Research and Clinical Oncology|January 27, 2024
Multi-omics and Multi-VOIs to predict esophageal fistula in esophageal cancer patients treated with radiotherapyWei Guo, Bing Li, Wencai Xu, et al.
European Journal of Cancer (Oxford, England : 1990)|September 22, 2024
Efficacy and safety of camrelizumab plus apatinib in patients with advanced esophageal squamous cell carcinoma previously treated with immune checkpoint inhibitors (CAP 02 Re-challenge): A single-arm, phase II studyXiangrui Meng, Junsheng Wang, Jin Xia, et al.
Pageof 2